IL143945A0 - Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same - Google Patents

Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same

Info

Publication number
IL143945A0
IL143945A0 IL14394500A IL14394500A IL143945A0 IL 143945 A0 IL143945 A0 IL 143945A0 IL 14394500 A IL14394500 A IL 14394500A IL 14394500 A IL14394500 A IL 14394500A IL 143945 A0 IL143945 A0 IL 143945A0
Authority
IL
Israel
Prior art keywords
preparation
choh
cor
novel
pharmaceutical compositions
Prior art date
Application number
IL14394500A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL143945A0 publication Critical patent/IL143945A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14394500A 1999-01-11 2000-01-07 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same IL143945A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900186A FR2788274B1 (fr) 1999-01-11 1999-01-11 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2000/000026 WO2000042027A1 (fr) 1999-01-11 2000-01-07 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IL143945A0 true IL143945A0 (en) 2002-04-21

Family

ID=9540746

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14394500A IL143945A0 (en) 1999-01-11 2000-01-07 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
IL143945A IL143945A (en) 1999-01-11 2001-06-21 New derivatives of polyhydroxypyrazine, preparations and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143945A IL143945A (en) 1999-01-11 2001-06-21 New derivatives of polyhydroxypyrazine, preparations and pharmaceutical preparations containing them

Country Status (24)

Country Link
US (1) US6818637B2 (ja)
EP (1) EP1140861B1 (ja)
JP (1) JP4516694B2 (ja)
KR (1) KR100648324B1 (ja)
CN (1) CN1145615C (ja)
AT (1) ATE244226T1 (ja)
AU (1) AU774627B2 (ja)
BR (1) BR0007449B1 (ja)
CA (1) CA2359463C (ja)
CZ (1) CZ301380B6 (ja)
DE (1) DE60003631T2 (ja)
DK (1) DK1140861T3 (ja)
EA (1) EA003550B1 (ja)
ES (1) ES2198273T3 (ja)
FR (1) FR2788274B1 (ja)
HU (1) HU228761B1 (ja)
IL (2) IL143945A0 (ja)
NO (1) NO320398B1 (ja)
NZ (1) NZ512911A (ja)
PL (1) PL200682B1 (ja)
PT (1) PT1140861E (ja)
SK (1) SK286389B6 (ja)
WO (1) WO2000042027A1 (ja)
ZA (1) ZA200105657B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425596C (zh) * 2006-03-29 2008-10-15 中国烟草总公司郑州烟草研究院 脱氧果糖嗪的制备方法
CN101697972B (zh) * 2009-11-16 2011-08-10 朱峰 新曲霉酸在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU704139B2 (en) * 1995-11-22 1999-04-15 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
FR2766185B1 (fr) * 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation

Also Published As

Publication number Publication date
CA2359463C (fr) 2009-09-15
EP1140861B1 (fr) 2003-07-02
DK1140861T3 (da) 2003-10-20
CN1352638A (zh) 2002-06-05
ATE244226T1 (de) 2003-07-15
AU3051500A (en) 2000-08-01
JP2002534513A (ja) 2002-10-15
NO20013416L (no) 2001-09-06
PL200682B1 (pl) 2009-01-30
EP1140861A1 (fr) 2001-10-10
DE60003631D1 (de) 2003-08-07
DE60003631T2 (de) 2004-06-03
HUP0105104A2 (hu) 2002-07-29
ZA200105657B (en) 2002-10-10
FR2788274B1 (fr) 2001-02-09
NO20013416D0 (no) 2001-07-10
ES2198273T3 (es) 2004-02-01
BR0007449B1 (pt) 2011-08-09
CN1145615C (zh) 2004-04-14
KR100648324B1 (ko) 2006-11-23
KR20010101456A (ko) 2001-11-14
NZ512911A (en) 2003-10-31
HUP0105104A3 (en) 2002-09-30
PT1140861E (pt) 2003-11-28
EA003550B1 (ru) 2003-06-26
US20020077324A1 (en) 2002-06-20
CZ20012483A3 (cs) 2001-10-17
JP4516694B2 (ja) 2010-08-04
BR0007449A (pt) 2001-10-16
NO320398B1 (no) 2005-11-28
CA2359463A1 (fr) 2000-07-20
AU774627B2 (en) 2004-07-01
CZ301380B6 (cs) 2010-02-03
IL143945A (en) 2006-04-10
HU228761B1 (en) 2013-05-28
FR2788274A1 (fr) 2000-07-13
EA200100767A1 (ru) 2001-12-24
PL348768A1 (en) 2002-06-03
SK9762001A3 (en) 2001-12-03
US6818637B2 (en) 2004-11-16
SK286389B6 (sk) 2008-09-05
WO2000042027A1 (fr) 2000-07-20

Similar Documents

Publication Publication Date Title
ATE180257T1 (de) Pyrazolderivate
AU563683B2 (en) Substituted acyl derivative of 1,2,3,4-tetrahydroiso- quinoline-3-carboxylic acid
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
DK0635499T3 (da) Nye acaricidt aktive tetrazinderivater
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
IL143945A0 (en) Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
AU576926B2 (en) Tetrazole derivatives
DE3772235D1 (de) Thianaphthen-derivate, ihre herstellung und verwendung.
ES8505332A1 (es) Procedimiento para la fabricacion de derivados del acido benzoico con actividad antimicrobiana
EP1156057A4 (en) MALTO-OLIGOSACCHARID DERIVATIVES AND THEIR APPLICATIONS
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
YU65800A (sh) Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2)diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje terapeutski aktivnih jedinjenja
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
ES2007784A6 (es) Procedimiento para la preparacion de derivados de 1-alquil-ergolinil-tiourea>
AU6101890A (en) Therapeutic agents for the treatment of peptic ulcer disease
IL153780A0 (en) Dimethylbenzene derivatives
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
IE38766L (en) O-haloalkylphosphoric acid ester amides
HU9400795D0 (en) Benzene derivatives and pharmaceutical compositions containing them as active components
ES275437A1 (es) Procedimiento para la preparaciën de nuevas aminas
GB822517A (en) N-substituted-4-phenyl-4-carboxylic piperidines and the preparation thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed